Investigating the role of the growth hormone–insulin-like growth factor (GH–IGF) axis as a determinant of male bone mineral density (BMD)
- 31 December 2005
- journal article
- research article
- Published by Elsevier BV in Bone
- Vol. 37 (6), 833-841
- https://doi.org/10.1016/j.bone.2005.06.016
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Osteoporosis in MenRheumatic Disease Clinics of North America, 2001
- Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver diseaseHepatology, 1997
- Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet recordsBritish Journal of Nutrition, 1994
- Low plasma levels of insulin‐like growth factor 1 (IGF‐1) in male patients with idiopathic osteoporosisJournal of Internal Medicine, 1992
- Urinary excretion of human growth hormone in children with short stature: Correlation with pituitary secretion of human growth hormoneThe Journal of Pediatrics, 1992
- Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developmentsJournal of Endocrinology, 1989
- Growth hormone receptor and serum binding protein: purification, cloning and expressionNature, 1987
- Urine Growth Hormone Determinations Compared with Other Methods in the Assessment of Growth Hormone SecretionActa Paediatrica, 1987
- Treatment of osteoporosis with calcitonin, with and without growth hormoneMetabolism, 1985
- Impaired Growth Hormone Responses to Growth Hormone–Releasing Factor in ObesityNew England Journal of Medicine, 1984